Memphis Pharmaceuticals

مادة اعلانية

Latest Update: 27 Oct 2026 15:29 Abu Dhabi Time.

Market Status: Closed

MPCI

Memphis Pharmaceuticals

275.00

EGP

25.000

10.00%

Open

250.00

Prev Close

250.00

PX_VOLUME

336,133

MARKET CAP (M)

DAY RANGE

256.00 - 278.90

52 WEEKS

130.00 - 490.86

Stock Statistics

Yearly Change

12.11%

Listed Shares (Million)

22.75

Earnings Multiple

11.85

Average 30-day trading volume

392,085.74

Price-to-book ratio

6.74

Earnings Per Share

21.10

Previous Dividend Distribution

12.53

Dividend Yield

5.27%

Financial Summary

Quarterly
Annual

Income Statements

	Period Ending:	Jun 30, 2026	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023
Total Revenue		313.02	437.38	457.63	497.89	410.53	309.36	388.26	399.66	207.33	234.79	247.14	182.65
Gross Profit		142.84	159.92	179.09	203.53	176.48	130.23	189.82	187.25	70.43	75.84	100.90	53.12
Operating Income		94.79	124.96	150.23	173.60	145.15	98.94	136.20	149.06	51.45	45.44	64.59	26.64
Profit Margin		29.13	24.46	28.15	30.72	31.55	34.81	32.77	35.24	12.10	35.56	23.52	13.56

	Period Ending:	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Total Revenue		1,705.93	1,507.80	871.91	663.83	551.26	518.11
Gross Profit		685.38	683.78	300.29	212.95	149.39	164.98
Operating Income		543.58	528.91	188.12	98.85	71.04	36.24
Profit Margin		28.13	33.51	21.96	13.62	13.44	8.07

Balance Sheet

	Period Ending:	Jun 30, 2026	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023
Total Assets		1,489.88	1,528.79	1,577.55	1,646.86	1,492.80	1,483.67	1,343.04	1,330.93	1,217.04	1,127.34	1,004.16	795.79
Total Liabilities		646.59	712.10	867.84	1,052.45	722.27	823.09	960.80	1,042.41	1,067.96	1,059.62	856.04	667.63
Total Equity		843.29	816.69	709.71	594.41	770.54	660.58	382.23	288.51	149.08	67.73	148.12	128.16

	Period Ending:	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Total Assets		1,489.88	1,492.80	1,217.04	785.66	560.29	431.58
Total Liabilities		646.59	722.27	1,067.96	680.70	523.65	469.77
Total Equity		843.29	770.54	149.08	104.95	36.64	-38.18

Cash Flows Statements - Coming Soon

* In Million of Egypt Pound

Reminder: The financial information on this website is delayed information that are originates from certified data providers in the financial markets, who retain the rights and intellectual property of this data, absolving ADMN of any responsibility.

MPCI

Memphis Pharmaceuticals